Abstract

VENTILATOR ASSOCIATED PNEUMONIA INCIDENCE, TREATMENT AND IMPACTS: A DETAIL REVIEW

Faiza Khan, Maqsood Ahmed Khan, Shazia Alam, Zeb-Un-Nisa, Hira Akhtar, Saira Shahnaz*

ABSTRACT

Introduction: The Ventilator associated pneumonia (VAP) is a common condition with inflammation of lungs. The patients on mechanical ventilation or artificial breathings for 48 to72 hours tend to developed this condition. which is a type of Nosocomial Pneumonia. Objective: A systemic review was performed to analyses the incidence, prevalence, clinical diagnosis and possible treatment of VAP. Methodology: The study was conducted by selecting the cross sectionals, randomized trails and observational studies to extract the data related to terms required by the study. The matched studies, representing the cohorts were included in the data to calculate and predicts the mortality rates, length of stay at hospitals. Results: The study found out that the VAP is most type of hospital acquired pneumonia form the health care system. The study also assesses by comparing the results to past studies that people having compromised breathing requiring the ventilators supports are two times more likely to catch the VAP, ventilators support >48 hours have around 20-30% (Mean 6.9 days CI: 1.16-3.65) chance to develop the VAP. The subsequent effects of VAP shows the two-fold rates of mortality hence requiring the more length of stay at hospital and extra charges. Conclusion: The VAP occurs among the considerable numbers of patients on the ventilator supports, the findings suggests that an appropriate management, prevention strategies and effective treatment is needed to reduces the mortality and complications of VAP.

Keywords: Ventilator-associated pneumonia, Mortality, Incidence, Prevention, Nosocomial pneumonia.